Andrew Haydon Clinical Oncology Society of Australia Annual Scientific Meeting 2019

Abstracts this author is presenting:

• Update on Overall Survival in COLUMBUS: A Randomized Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) vs Vemurafenib (VEM) or ENCO in Patients With BRAF V600–Mutant Melanoma — Poster Session 2
• Correlation of Primary Melanoma Tumour Mitotic Count and Tumour Infiltrating Lymphocytes with Response to Immunotherapy — Poster Session 2